Please login to the form below

Not currently logged in
Email:
Password:

Urovant

This page shows the latest Urovant news and features for those working in and with pharma, biotech and healthcare.

Sumitomo Dainippon goes big on biotech with $3bn Roivant deal

Sumitomo Dainippon goes big on biotech with $3bn Roivant deal

The five companies Sumitomo is set to take over from Roivant include Myovant, Urovant, Enzyvant, Altavant and another undisclosed spinout company. ... Although Sumitomo will gain a major stake in Urovant and Myovant (75% and 45%), the Japanese pharma

Latest news

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...

Infographics